Phase 1 Study to Evaluate the Safety and Drug-Drug Interactions in Healthy Adult Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This Phase 1 study will evaluate the safety and drug‐drug interactions of AG2203L andAG2203E in healthy adult participants. Participants will receive AG2203L and AG2203Ealone and in combination during three treatment periods according to one of six randomlyassigned treatment sequences.
Epistemonikos ID: d82e1336c29c2430aba394e56ac5bc4081a639e8
First added on: Sep 01, 2026